The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content


Cardiome Pharma Corp closed at $5.33.

Over the last five days, shares have gained 4.10% and 42.13% year to date. Shares have underperformed the S&P TSX by 26.97% during the last year.

Key company metrics

  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS-$1.23
Updated June 26 1:54 PM EDT. Delayed by at least 15 minutes.


Net Profit (TTM)

Although this company's net profit margin is negative, it is above the industry average and implies that Cardiome Pharma Corp is operating more effectively than other companies in the industry.
Company Books

S&P TSX0.02%Sector:HealthcareIndustry:Biotechnology

Latest Company News

View more News

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016
Total other revenue--------
Total revenue5756
Gross profit4544
Total cost of revenue2212
Total operating expense1112912
Selling / general / administrative8978
Research & development--000
Depreciation / amortization1111
Interest expense (income), net operating--------
Unusual expense (income)--001
Other operating expenses, total--------
Operating income-5-5-4-6
Interest income (expense), net non-operating-1-1-10
Gain (loss) on sale of assets--------
Income before tax-6-6-5-7
Income after tax-6-6-5-8
Income tax, total0000
Net income-6-6-5-8
Total adjustments to net income--------
Net income before extra. items-6-6-5-8
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-6-6-5-8
Inc. avail. to common incl. extra. items-6-6-5-8
Diluted net income-6-6-5-8
Dilution adjustment--------
Diluted weighted average shares32322820
Diluted EPS excluding extraordinary itemsvalue per share-0.20-0.18-0.19-0.37
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share-0.20-0.18-0.19-0.32